TERN-601

5 Obesity Readouts to Watch in the Second Half of 2024
BioSpace
Tue, 08/13/24 - 11:47 am
obesity
clinical trials
Novo Nordisk
CagriSema
Amgen
MariTide
Monlunabant
Aphaia Pharma
APHD-012
Terns Pharmaceuticals
TERN-601